Start with the identity of this publication
The ownership disclosure names CoreAge Rx as the publisher. The word “legit” in a website name is not an independent accreditation or a finding that a particular transaction was handled correctly. This article uses public company information and outside records; it does not report a patient enrollment, pharmacy inspection or independent clinical audit.
An outside record matters here: BBB’s CoreAge Rx profile, checked October 15, 2026, lists an F rating, no accreditation and alerts. Its complaint-pattern account describes allegations about delivery, support and billing, and a closed inquiry that BBB says was not addressed. These are attributed reports, not adjudicated findings; this review has not established that the concerns were resolved.
A platform name does not identify everyone delivering care
An online service can arrange intake and administration while a clinician makes a prescribing decision and a pharmacy dispenses the medicine. Ask for the legal or professional name connected with each role. A mailing address on a company policy is not proof that a medical visit or pharmacy operation takes place there.
Our prescriber and pharmacy guide explains how to organize those checks. Obtain the treating clinician’s full name and the relevant state license information, then consult the appropriate licensing board. This review did not receive an assigned clinician or verify a specific license. A general claim about the company’s medical network cannot substitute for that individual check.
Check the dispensing pharmacy against the prescription
FDA’s pharmacy-finder resource directs readers to state board databases. Its online-pharmacy checks include requiring a prescription, having a U.S. address and telephone number, and making a licensed pharmacist available. Use the actual pharmacy name from the proposed order, rather than assuming that every pharmacy mentioned in marketing will dispense your medicine.
Confirm that the pharmacy can serve your location and ask how to reach its pharmacist with a labeling or storage question. Compare the name on the shipment with the written information you received. We have not examined a prescription, shipment or batch for this article, so the review cannot confirm the quality or identity of a product supplied to an individual patient.
Keep product approval separate from business verification
The checked semaglutide and tirzepatide pages describe compounded products. FDA’s safety information explains that compounded drugs are not FDA-approved and do not undergo its premarket review for safety, effectiveness and quality. A licensed business or clinician does not convert a compounded preparation into an approved medicine.
The approval and compounding explainer distinguishes these categories. Ask the clinician why the proposed product meets your medical needs and whether an approved option could meet them. Do not assume that a familiar ingredient name proves equivalence to an approved brand, or that a business-review score answers a clinical question.
Verify the offer attached to the order you select
The public starting figures checked for this review were $79 per month for compounded semaglutide and $129 for compounded tirzepatide. The pages advertise no membership fee and included delivery. These statements do not identify the total charge, supply quantity or renewal schedule for every treatment selection.
Read the selected checkout with the current refund and shipping policy. The policy describes possible non-refundable consultation fees of $50–$100 once provider review begins, including when treatment is declined. Ask which charges apply before submitting payment; a low advertised monthly figure does not establish the cost of every order or every outcome of clinical assessment.
Record what has happened before requesting a cancellation
The policy distinguishes canceling future subscription renewals from canceling an existing order. It states that an order can become final after provider approval and transmission for pharmacy fulfillment, even before shipment. It also states a 30-day refund cutoff from purchase, including incomplete orders, except where law requires otherwise. These are the company’s stated terms, not this publication’s conclusion about their enforceability.
Keep the purchase receipt, intake-completion time, clinical messages and pharmacy status. The policy separates an estimated order-completion period from an estimated delivery period after shipment. A payment timestamp is not a pharmacy dispatch timestamp. If a disputed charge or missing order remains unresolved, document the company’s answer rather than treating a promotional assurance as a resolution.
Use verification to support a clinical conversation
A useful file contains the exact offer, identities of the assigned professionals, the product description, follow-up arrangements and dated policy. Keep any unanswered point visible. The treatment-assessment guide explains why a screening number does not guarantee a prescription or make one medicine suitable for everyone.
Sources were checked October 15, 2026. Prices, records and terms can change. This review gives readers a way to evaluate the public offer and ask specific questions; it does not issue a blanket certification of the service or a recommendation that any individual start treatment.
Common questions
Has this review verified my assigned clinician or pharmacy?
No. It uses public information and explains how to obtain and check the names associated with an actual prescription.
Does a pharmacy license make a compounded medicine FDA-approved?
No. Professional or facility licensing and FDA product approval are different questions.
Is this an independent review site?
No. CoreAge Rx owns and publishes this website. The review identifies that relationship and links outside records.
Sources and fact-checking
Sources checked 2026-10-15. CoreAge Rx pages support descriptions of its service; medical and regulatory sources support the educational context. Offers and availability can change.